A decreased LRR risk was also observed in patients who received ET, with borderline significance by Gray’s test.
← all excerpts
A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer.
1
—
—